This brand name is authorized in Nigeria.
The drug EMZIFIX contains one active pharmaceutical ingredient (API):
1
|
UNII
97I1C92E55 - CEFIXIME
|
|
Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-8311 | Tablet | EMZIFIX 200MG TABLET TAB 200 mg 1 X 10 | 23 CMS-PP-290232 EMZIFIX 200MG TABLET CEFIXIME TRIHYDRATE CEFIXIME 200MG A4-8311 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 1x10 POM 1 12/12/2022 EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, plot 3c blk aswani market road isolo 14805555 chinelo@emzorpharma.com EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, FLOWERGATE MIXED DEVELOPMENT SCHEME, KM1, SAGAMU-BENIN EXPRESSWAY, MAKUN, SAGAMU, Nigeria | 06/07/2023 |
| A4-8312 | Tablet | EMZIFIX 400MG TABLET TAB 400 mg 1 X 10 | 24 CMS-PP-290236 EMZIFIX 400MG TABLET CEFIXIME TRIHYDRATE CEFIXIME 400MG A4-8312 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 1x10 POM 1 12/12/2022 EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, plot 3c blk aswani market road isolo 14805555 chinelo@emzorpharma.com EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, FLOWERGATE MIXED DEVELOPMENT SCHEME, KM1, SAGAMU-BENIN EXPRESSWAY, MAKUN, SAGAMU, Nigeria | 06/07/2023 |
| A4-8313 | Powder for suspension | EMZIFIX POWDER FOR ORAL SUSPENSION PWD_F_SOL 100 mg/5 mL 60ml | EMZIFIX POWDER FOR ORAL SUSPENSION CEFIXIME TRIHYDRATE CEFIXIME 100MG/5ML A4-8313 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 60ml POM 1 12/12/2022 EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, plot 3c blk aswani market road isolo 14805555 chinelo@emzorpharma.com EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, FLOWERGATE MIXED DEVELOPMENT SCHEME, KM1, SAGAMU-BENIN EXPRESSWAY, MAKUN, SAGAMU, Nigeria | 27/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DD08 | Cefixime | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-8311, A4-8312, A4-8313 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.